141 related articles for article (PubMed ID: 27221054)
21. Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro.
Kamen BA; Smith AK
Cancer Chemother Pharmacol; 2012 Jul; 70(1):113-20. PubMed ID: 22644798
[TBL] [Abstract][Full Text] [Related]
22. Folic Acid-Conjugated Pyropheophorbide a as the Photosensitizer Tested for In Vivo Targeted Photodynamic Therapy.
Wang J; Liu Q; Zhang Y; Shi H; Liu H; Guo W; Ma Y; Huang W; Hong Z
J Pharm Sci; 2017 Jun; 106(6):1482-1489. PubMed ID: 28263847
[TBL] [Abstract][Full Text] [Related]
23. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
24. [FRα: a target for prophylactic photodynamic therapy of ovarian peritoneal metastasis?].
Azaïs H; Moussaron A; Khodja Bach S; Bassil A; Betrouni N; Frochot C; Collinet P; Mordon S
Bull Cancer; 2014 Dec; 101(12):1109-13. PubMed ID: 25532689
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer.
Kato T; Jin CS; Ujiie H; Lee D; Fujino K; Wada H; Hu HP; Weersink RA; Chen J; Kaji M; Kaga K; Matsui Y; Wilson BC; Zheng G; Yasufuku K
Lung Cancer; 2017 Nov; 113():59-68. PubMed ID: 29110850
[TBL] [Abstract][Full Text] [Related]
26. Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: Synthesis and photophysical properties.
Stallivieri A; Colombeau L; Jetpisbayeva G; Moussaron A; Myrzakhmetov B; Arnoux P; Acherar S; Vanderesse R; Frochot C
Bioorg Med Chem; 2017 Jan; 25(1):1-10. PubMed ID: 27769669
[TBL] [Abstract][Full Text] [Related]
27. Folic acid mediates activation of the pro-oncogene STAT3 via the Folate Receptor alpha.
Hansen MF; Greibe E; Skovbjerg S; Rohde S; Kristensen AC; Jensen TR; Stentoft C; Kjær KH; Kronborg CS; Martensen PM
Cell Signal; 2015 Jul; 27(7):1356-68. PubMed ID: 25841994
[TBL] [Abstract][Full Text] [Related]
28. Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin.
Hamblin MR; Newman EL
J Photochem Photobiol B; 1994 Oct; 26(1):45-56. PubMed ID: 7799139
[TBL] [Abstract][Full Text] [Related]
29. Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy.
You H; Yoon HE; Jeong PH; Ko H; Yoon JH; Kim YC
Bioorg Med Chem; 2015 Apr; 23(7):1453-62. PubMed ID: 25753328
[TBL] [Abstract][Full Text] [Related]
30. Graphene oxide-incorporated pH-responsive folate-albumin-photosensitizer nanocomplex as image-guided dual therapeutics.
Battogtokh G; Ko YT
J Control Release; 2016 Jul; 234():10-20. PubMed ID: 27164545
[TBL] [Abstract][Full Text] [Related]
31. Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)chlorin (m-THPC).
Moret F; Scheglmann D; Reddi E
Photochem Photobiol Sci; 2013 May; 12(5):823-34. PubMed ID: 23385966
[TBL] [Abstract][Full Text] [Related]
32. Folate Receptor Targeted Photodynamic Therapy: A Novel Way to Stimulate Anti-Tumor Immune Response in Intraperitoneal Ovarian Cancer.
Baydoun M; Boidin L; Leroux B; Vignion-Dewalle AS; Quilbe A; Grolez GP; Azaïs H; Frochot C; Moralès O; Delhem N
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511049
[TBL] [Abstract][Full Text] [Related]
33. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
[TBL] [Abstract][Full Text] [Related]
34. New porphyrin amino acid conjugates: synthesis and photodynamic effect in human epithelial cells.
Serra VV; Zamarrón A; Faustino MA; Cruz MC; Blázquez A; Rodrigues JM; Neves MG; Cavaleiro JA; Juarranz A; Sanz-Rodríguez F
Bioorg Med Chem; 2010 Aug; 18(16):6170-8. PubMed ID: 20638288
[TBL] [Abstract][Full Text] [Related]
35. Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy.
Liu J; Zhao D; He W; Zhang H; Li Z; Luan Y
J Colloid Interface Sci; 2017 Feb; 487():239-249. PubMed ID: 27776282
[TBL] [Abstract][Full Text] [Related]
36. A versatile and multifunctional metal-organic framework nanocomposite toward chemo-photodynamic therapy.
Pan Y; Luo Z; Wang X; Chen Q; Chen J; Guan Y; Liu D; Xu H; Liu J
Dalton Trans; 2020 Apr; 49(16):5291-5301. PubMed ID: 32242552
[TBL] [Abstract][Full Text] [Related]
37. Structural basis for molecular recognition of folic acid by folate receptors.
Chen C; Ke J; Zhou XE; Yi W; Brunzelle JS; Li J; Yong EL; Xu HE; Melcher K
Nature; 2013 Aug; 500(7463):486-9. PubMed ID: 23851396
[TBL] [Abstract][Full Text] [Related]
38. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
Müller C; Struthers H; Winiger C; Zhernosekov K; Schibli R
J Nucl Med; 2013 Jan; 54(1):124-31. PubMed ID: 23236020
[TBL] [Abstract][Full Text] [Related]
39. Biotin/Folate-decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer.
Nateghian N; Goodarzi N; Amini M; Atyabi F; Khorramizadeh MR; Dinarvand R
Chem Biol Drug Des; 2016 Jan; 87(1):69-82. PubMed ID: 26216713
[TBL] [Abstract][Full Text] [Related]
40. Tumour-targeting photosensitisers for one- and two-photon activated photodynamic therapy.
Jenni S; Sour A; Bolze F; Ventura B; Heitz V
Org Biomol Chem; 2019 Jul; 17(27):6585-6594. PubMed ID: 31032834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
